Asia Pacific 3D printed surgical models market will grow by 15.1% annually with a total addressable market cap of $ 2,661.8 million over 2023-2032, driven by the increasing healthcare spending, upsurge in demand for minimally invasive procedures, a rising incidence of chronic diseases, and technology advancements in 3D printing.
Highlighted with 38 tables and 83 figures, this 150-page report “Asia Pacific 3D Printed Surgical Models Market 2022-2032 by Specialty (Orthopedic, Cardiology, Gastroenterology, Neurosurgery, Oncology, Reconstructive, Transplant), Material (Plastics, Metal, Polymer, Others), Technology (FDM, SLA, MultiJet/PolyJet, CJP), End User (Hospitals, Clinics, ASCs), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific 3D printed surgical models market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces


The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific 3D printed surgical models market in every aspect of the classification from perspectives of Specialty, Material, Technology, End User, and Country.

Based on Specialty, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Orthopedic Surgery


o Hip Replacement Revision
o Repair Intervertebral Disc
o Repair Scoliosis
o Hip Repair
o Repair Clavicle Fracture
o Osteotomy
o Repair Leg Fracture

  • Cardiac Surgery/Interventional Cardiology


o Annuloplasty/Mitral Valve Repair
o Replacement of Aortic Valve
o Repair Coronary Aneurysm
o Stent Insertion
o Repair of Congenital Heart Defects

  • Gastroenterology Endoscopy of Esophageal


o Endoscopy of Esophageal Lesion
o Splenectomy

  • Neurosurgery


o Remove Brain Tumor
o Repair Aneurysm
o Transsphenoidal Excision of Pituitary Gland

  • Surgical Oncology


o Endoscopic Removal of Cardiac Lesion
o Removal of Adrenal Tumor
o Thoracic Removal of Lung Tumor
o Removal of Renal Tumor
o Removal of Liver Tumor

  • Reconstructive Surgery


o Facial Reconstruction
o Cleft Palate Correction
o Breast Reconstruction
o Hand Reconstruction
o Mastoidectomy

  • Transplant Surgery


o Heart Transplant
o Cardiac Surgery/Interventional Cardiology
o Kidney Transplant
o Liver Transplant
o Lung Transplant

Based on Material, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Plastics
  • Metal
  • Polymer
  • Other Material Types



By Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Fused Deposition Modeling (FDM)
  • Stereolithography (SLA)
  • MultiJet/PolyJet Printing
  • ColorJet Printing (CJP)
  • Other Technologies



By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASCs)



Geographically, the following national/local markets are fully investigated:

  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)


For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Specialty, Material and Technology over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
3D Lifeprints U.K. Ltd.
3D Systems, Inc.
Axial3D Ltd.
Formlabs, Inc.
Lazarus 3D, LLC
Materialise N.V.
Onkos Surgical, Inc.
Osteo3D
Stratasys Ltd.
Stryker Corp.
Whiteclouds
Zimmer Biomet Holdings, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)